IQVIA艾昆纬：2025年CAR-T细胞疗法卫生系统就绪度评估报告：障碍与机遇（英文版）

In this report, the current health system capacity for delivering CAR T-cell therapies to patients was assessed in seven countries (Australia, Canada, France, Germany, Italy, Spain, and the United Kingdom). This includes reimbursement and funding, patient referral, treatment, and long-term follow-up. This report provides background on the complex CAR T-cell therapy patient journey from patient identification and referral to long-term monitoring, and estimates CAR T-cell therapy utilization in